A show discussing the important academic and other research in the field of Psychedelics. We discuss how psychedelics relate to human potential and healing.
psychedelics, integration, solidarity, consciousness, relatively, efforts, states, amazing guests, leading, besides, example, great topics, great resource, met, field, educational, chance, fascinating.
Listeners of Psychedelics Today that love the show mention: kyle and joe, joe and kyle,The Psychedelics Today podcast is an excellent resource for anyone interested in the psychedelic space. It provides valuable content and keeps listeners up to date on the latest happenings in the field. The podcast features a variety of voices, offering diverse perspectives without any hype. It encourages listeners to think, learn, and explore further.
One of the best aspects of this podcast is its coverage of the legitimization of psychedelic experiences in therapy, spirituality, and recreation. The hosts bring many voices to the table and strive to mainstream the conversation surrounding psychedelics. This approach is refreshing and serves humanity by promoting education and awareness.
Another standout aspect of the podcast is that it acknowledges differing opinions within the industry. It addresses scientific viewpoints that may look down on or show contempt for those who choose not to go to a clinic or work with a psychiatrist for their psychedelic experience. By including multiple perspectives, the podcast allows listeners to consider both sides of the discussion.
A possible drawback of this podcast is that it may not delve into scientific topics deeply enough for some scientists or experts in the field. While it covers the science behind psychedelics, it does so in a way that non-scientists can follow. This approach may be appreciated by beginners or those seeking a general understanding but may leave some wanting more detailed scientific discussions.
In conclusion, The Psychedelics Today podcast is highly recommended for anyone new to the psychedelic movement or seeking up-to-date information on psychedelics. It offers informative interviews with experts and covers a wide range of topics without overwhelming listeners with technical jargon. With each episode, it continues to improve and deliver valuable content. Whether you're curious about psychedelics, interested in therapy options, or simply looking to expand your knowledge, this podcast is worth listening to.
In this episode, Joe Moore speaks with award-winning science journalist Erica Rex about her personal experience participating in psychedelic research, her upcoming book Seeing What Is There: My Search for Sanity in the Psychedelic Era, and the complex story behind the recently published Religious Leader Psilocybin Study from Johns Hopkins and NYU. They examine: Erica's firsthand experience as a participant in the original 2012 study that helped launch Roland Griffiths' prominence in psychedelic science. The goals and outcomes of the Religious Leader Study, which sought to explore how psilocybin might impact religious leaders' effectiveness and connection to their communities. The methodological and ethical problems that plagued the study. The influence of perennialist frameworks and the limitations of measures like the Mystical Experience Questionnaire (MEQ). Broader concerns about the infiltration of religious ideology and lack of rigor in psychedelic science. A deep critique of the institutional systems that allowed flawed research processes to go unchecked — and how these patterns risk repeating the mistakes of the 1960s psychedelic wave. Joe and Erica also dive into how modern psychedelic science struggles to reconcile subjective experience, spirituality, and the reductionist standards of academic research. They discuss Matt Johnson's paper critiquing “psychedelic consciousness” framing and explore whether our current scientific tools are capable of capturing the depth of psychedelic experience. Erica's forthcoming book, slated for release in January 2026, blends memoir, neuroscience, and social critique. It offers a critical insider's view of the psychedelic renaissance—its promise, pitfalls, and the ways it mirrors broader systemic issues in science and culture.
In this expansive episode of Psychedelics Today, Joe Moore sits down with author and cultural theorist Daniel Pinchbeck to explore the evolving—and increasingly contested—role of psychedelics in society. From the hopeful spirit of transformation that animated earlier psychedelic movements to the sobering reality of biotech, branding, and political entanglement, Daniel offers a candid diagnosis of where we are—and where we might be headed. Reflecting on Psychedelic Science 2025, Daniel discusses the event's stark shift toward commercialization and industry influence. He contrasts this with his earlier work on Evolver, a movement that sought to integrate psychedelics with permaculture, alternative economics, and cultural awakening. Together, Joe and Daniel examine how the field's idealistic origins have been increasingly subjected to capitalist co-option. They also dive into deeper philosophical terrain—discussing monistic idealism, Rudolf Steiner, and the suppression of mystical and paranormal dimensions in the push to medicalize and sanitize psychedelics for mainstream acceptance. Daniel warns of the dangers of ignoring the shadow, including psychic fragmentation and what he calls "entity attachment" from ungrounded use. The conversation ranges from tech billionaires on ketamine to the geopolitical threat of authoritarianism, the weaponization of AI, and the quiet complicity of many in the psychedelic space who avoid political engagement. Daniel shares his current projects, including his Substack newsletter and a new seminar, Breaking the AI Barrier. This is a timely, unflinching exploration of psychedelics as both medicine and mirror—revealing the best and worst of our collective intentions. Can we reclaim the visionary potential of these tools from the grip of capital and control?
In this wide-ranging conversation, journalist Mattha Busby joins Joe Moore to reflect on the shifting tone of the psychedelic movement in the wake of Psychedelic Science 2025. Based in Vancouver, Mattha has written for The Guardian, VICE, Esquire, TIME, and Wired, bringing a uniquely embedded yet critical lens to the space. They discuss the post-conference mood and the sense that the industry is sobering up—less hype, more introspection. Mattha reflects on the growing division between underground practitioners, activists, and biotech startups, and the importance of vision, ethics, and scrutiny in the midst of this cultural moment. Other topics include: Ketamine overuse and dependence, especially in social and parenting contexts The future of psychedelic nightlife, harm reduction, and mocktail bars Gender and sexual fluidity as uncovered through psychedelics Questions of IP, underground wisdom, and psychedelic ownership Psychedelics as tools for peacebuilding, especially in conflict zones The shadow side of spiritual experiences and how to spot bad actors The value of pleasure, intimacy, and human connection in the psychedelic journey Joe and Mattha also reflect on the resurgence of psychedelic use in Texas, the legacy of the Stark Club, and how Christian libertarianism and military trauma might influence unexpected policy changes. This conversation is bold, honest, funny, and thoughtful—exactly the kind of cultural critique the movement needs right now. Find Mattha on Instagram at @matthamundo and on LinkedIn at Mattha Busby. His new pocketbook on drug policy is available now.
Dylan Beynon: At-Home Ketamine Therapy, Big Pharma Pushback, and the Future of Psychedelic Accessibility In this episode, Joe Moore welcomes Dylan Beynon, CEO and Founder of Mindbloom, one of the largest providers of legal, at-home ketamine therapy in the U.S. Dylan shares the deeply personal story that led him to psychedelic medicine—including the tragic loss of his mother and sister to addiction and mental illness—and how these experiences continue to fuel his mission to make psychedelic therapy affordable and accessible for all. Mindbloom has now facilitated over 654,000 sessions across 38 states, offering both sublingual and subcutaneous (injectable) ketamine in a comprehensive treatment program that includes preparation, integration, music, journaling, and even generative AI art. The conversation dives into common criticisms of at-home ketamine, the benefits of guided treatment over IV infusions, and the disturbing influence of Big Pharma in media narratives—especially the growing PR push behind SPRAVATO. Dylan also breaks down what makes Mindbloom's outcomes stand out, why they recently added injectable ketamine, and how their safety data challenges popular misconceptions. Joe and Dylan also touch on the potential future of at-home MDMA therapy, regulatory hurdles, and what it will take to scale these powerful treatments to millions of people in need. If you're in the psychedelic field, considering ketamine therapy, or curious about the ethics and economics of psychedelic medicine, this episode offers a powerful look behind the curtain. Resources: Mindbloom.com Vital Psychedelic Training
In this episode, we sit down with Victoria Litman, M.Div., J.D., LL.M., to discuss why the future of psychedelic access in the United States is being shaped not by federal agencies, but by the bold actions of individual states. As a legal scholar and writer focusing on drug policy, Victoria breaks down the significance of the FDA's 2024 rejection of psychedelic-assisted therapy, and why that decision might be less of a setback than it seems. We explore how state-level initiatives like Oregon's Psilocybin Services Act and Colorado's Natural Medicine Health Act are setting the stage for a new model of access—one rooted in harm reduction, personal liberty, and existing regulatory infrastructure. Victoria discusses the importance of the Tenth Amendment and the Anti-Commandeering Doctrine, which allow states to move forward regardless of federal inaction. Rather than waiting for slow-moving federal institutions, Victoria argues that states can build safe, scalable systems now—especially by leveraging cannabis infrastructure for psychedelic regulation. She also touches on the ethical and cultural implications of this transition, including protections for spiritual and religious use. If you're wondering what psychedelic policy will look like in the years ahead, this episode offers an insightful and hopeful roadmap. Link to CATO article
Joe Moore and Anne Philippi are hosts of the PS25 Morning Show! This one features Dee Dee Goldpaugh, LCSW and Tommaso Barba, PhDC! We talk about all things Sex and Psychedelics!
n this episode of Psychedelics Today, kicking of Psychedelic Science 2025 week in Denver, we sit down with Jonathan Dicksinson, Chief Executive Officer, and Trevor Millar, Chief Operations Officer of Ambio Life Sciences – one of the world's leading ibogaine clinics – to explore the potential of ibogaine for addiction, neuroregeneration, and how ethics, honoring experience, and sustainability will be key to delivering ibogaine at scale. Trevor shares his early work supporting marginalized populations in Vancouver's Downtown Eastside, which led to the founding of Liberty Root, one of Canada's first ibogaine clinics. Jonathan reflects on his apprenticeship in Mexican clinics, years of international advocacy with the Global Ibogaine Therapy Alliance, and drafting the first set of clinical guidelines for ibogaine detoxification. Together with paramedic and ibogaine safety protocols expert Jose Inzunza, they co-founded Ambio in Tijuana in 2021. They discuss: The unique safety standards Ambio has pioneered – including industry-wide clinical protocols and magnesium therapy to mitigate cardiac risk. Their scale: over 3,000 patients treated, with 100+ clients per month across five dedicated houses in Baja California. Ambio's groundbreaking neuroregenerative program for Parkinson's, MS, and traumatic brain injury – which has already drawn patients like Brett Favre and Clay Walker. How ibogaine appears to drive profound physiological change – including evidence of TBI reversal as shown in Stanford's 2024 study on Special Forces veterans. Why ibogaine isn't just a molecule – it opens a long-lasting “critical period” of neuroplasticity that must be supported with preparation, integration, and holistic care. The deeper story of sourcing: through his company Terragnosis, Jonathan is the only person with a legal export license for Tabernanthe iboga from Gabon, and Ambio is setting a precedent for reciprocal and ethical global supply chains. Their cautionary perspective on Texas' $50M push toward ibogaine clinical trials – and why the traditional “one drug, one indication” model misses the complexity and promise of psychedelic healing. They also make a compelling case that Ambio is already modeling what the future of psychedelic care should look like – not a single drug in a sterile clinical setting, but a comprehensive, integrated protocol combining preparation, medical oversight, and deep integration. “Start with the end in mind,” Trevor urges – Ambio isn't just part of the movement; it's the blueprint for how ibogaine could be delivered worldwide. Links: Ambio Website: https://ambio.life/ Significant lesion reduction and neural structural changes following ibogaine treatments for multiple sclerosis (Frontiers in Immunology, Feb 2025) Magnesium–ibogaine therapy in veterans with traumatic brain injuries (Nature Medicine, Jan 2024) Ibogaine reduced severe neuropathic pain associated with a case of brachial plexus nerve root avulsion (Frontiers in Pain Research, Aug 2023) Novel treatment of opioid use disorder using ibogaine and iboga in two adults (Journal of Psychedelic Studies, Jan 2020) Clinical Guidelines for Ibogaine-Assisted Detoxification Ambio Life Sciences Launches World's First Clinical Ibogaine Program for Patients With Neurodegenerative Conditions Bios: Jonathan Dickinson is the Chief Executive Officer and Co-Founder of Ambio Life Sciences. One of the world's leading experts on ibogaine, Jonathan brings over 15 years of experience in clinical care, traditional practice, and psychedelic research to his leadership at Ambio. A Mexico-licensed psychologist and former Executive Director of the Global Ibogaine Therapy Alliance, he authored the field's foundational safety guidelines and has published widely on ibogaine's therapeutic, cultural, and ecological significance. He holds the only active export license for Tabernanthe iboga root, led the first Nagoya-compliant export from Gabon, and was initiated into the Dissoumba/Fang tradition of Bwiti in 2014 and the Missoko tradition in 2022. He has co-authored peer-reviewed research on ibogaine's potential for trauma, TBI, pain, MS, and Parkinson's. At Ambio, he leads strategy, research, and innovation – advancing a globally scalable model of care that bridges tradition, science, and integrity. Trevor Millar is the Chief Operating Officer and Co-Founder of Ambio Life Sciences. A social entrepreneur and pioneer in ibogaine advocacy and treatment, Trevor brings over a decade of experience supporting individuals through addiction recovery, trauma healing, and post-treatment integration. His background includes co-founding the Canadian Psychedelic Association and serving as Chair of the Board for MAPS Canada. He has co-authored peer-reviewed research on ibogaine's applications for trauma, TBI, and opioid use disorder, and has been featured in award-winning documentaries including DOSED and In Waves and War. Grounded in personal experience and guided by a philosophical approach to healing, Trevor is helping shape a new model for ethical, integrative psychedelic care on a global scale. At Ambio, Trevor leads operations, strategic partnerships, and client experience – bridging clinical care with systems design, education, and public advocacy.
In this episode of Psychedelics Today, hosts sit down with Jeff Breau from Harvard Divinity School's Center for the Study of World Religions. Key themes include the intersection of psychedelics and religion, harm reduction practices, and the burgeoning psychedelic church movement. Jeff brings insights from his ethnographic research on psychedelic churches and discusses the importance of interdisciplinary collaboration for advancing understanding in this field. He also delves into the role of music in psychedelic therapy, critiques of the Mystical Experience Questionnaire (MEQ), and the potential for psychedelic chaplaincy. Tune in for an enlightening conversation on the evolving landscape of psychedelics in society and spirituality. 00:00 Introduction and Welcome 00:18 Music in Psychedelic Therapy 02:13 Cultural Context of Music in Therapy 06:08 Personal Journey into Psychedelics and Religion 08:40 Living at an Ashram and Spiritual Practices 15:52 Mystical Experience Questionnaire (MEQ) 33:01 Psychedelic Churches and Legal Challenges 46:11 The Intersection of Law and Religion 46:34 Emergence of Psychedelic Churches 48:41 The Democratization of Mystical Experiences 49:49 Technologies of Revelation 51:10 Novel Rituals and Spiritual Practices 53:49 Humor and Irreverence in Religion 56:44 Reevaluating the Term 'Cult' 01:10:11 Psychedelic Chaplaincy and Spiritual Care 01:18:44 Burning Man as a Model for Religiosity 01:22:43 The Rise of Iboga in American Christianity 01:25:56 Conclusion and Future Directions Links https://cswr.hds.harvard.edu/people/jeffrey-breau
In this episode, Joe Moore sits down with Paul Gillis-Smith from The Center for the Study of World Religions to discuss a range of fascinating topics. They begin by discussing the Harvard Divinity School and the CSWR's mission and history. The conversation delves into the work and legacy of Lisa Bieberman, a pivotal figure in the 1960s psychedelic harm reduction movement. It explores her contributions to the field through her Psychedelic Information Center. They also touch on the Quaker traditions and their intersection with LSD use, showing how spirituality and psychedelics can coalesce. Paul also talks about upcoming psychedelic and chaplaincy workshops, emphasizing the importance of spiritual care in psychedelic experiences. This episode is rich with historical insights and contemporary applications, making it a must-listen for anyone interested in psychedelics and spirituality. Paul Gillis-Smith @ CSWR Center for the Study of World Religions Psychometric brahman, psychedelic science: Walter Stace, transnational Vedanta, and the Mystical Experience Questionnaire 00:00 Introduction and Initial Setup 00:34 Meeting at Penn's Psychedelic Conference 01:14 Postdoctoral Presentations and Indigenous Plant Medicine 03:27 Understanding CSWR and Its Evolution 07:21 Harvard's Study of Psychedelics in Society and Culture 09:11 Personal Academic Journey and Interest in Psychedelics 11:58 Role at CSWR and Ongoing Projects 18:59 Lisa Bieberman: A Pioneer in Psychedelic Education 40:53 Quaker Theology of LSD 41:58 Meeting Structure and Frequency 42:46 Profound Simple Truths 45:41 Transition to Quakerism 48:45 The New Jerusalem Prophecy 53:02 Quakerism and Its Influence 01:11:25 Clinical Chaplaincy and Psychedelics 01:18:39 Conclusion and Future Projects
In this episode of Psychedelics Today, Joe Moore speaks with Dr. Simon Ruffell, a London-based psychiatrist, researcher, and curandero-in-training in the López Mahua lineage of the Shipibo tradition. Dr. Ruffell shares how his early fascination with psychiatry eventually led to a deep disillusionment with the limitations of conventional treatments—and a surprising pivot toward the Amazon. Now working at the intersection of Indigenous healing and clinical research, Ruffell describes his journey from medical school to shamanic apprenticeship. He offers insight into the Shipibo understanding of illness across three planes—spiritual, psychological, and physical—and how these ideas challenge Western frameworks. The conversation explores critical questions about the psychedelic renaissance: Are current clinical models missing the energetic and spiritual dimensions of healing? What are the risks of poorly held psychedelic sessions, and how can Indigenous knowledge guide safer practices? Dr. Ruffell advocates for deep training, cross-cultural respect, and collaborative models—such as pairing Indigenous healers with psychiatrists in clinical settings. He also discusses his work with Onaya Science and Onaya.io, organizations that partner with Indigenous communities to study the effects of ayahuasca, particularly in treating PTSD among military veterans. Early findings from their five-year study show that 84% of participants no longer meet PTSD criteria six months after retreat—a promising signal for integrative approaches. This episode offers a rare look at how science and spirituality can coexist. Whether you're a clinician, researcher, or someone seeking deeper healing, Dr. Ruffell's story invites us to question our assumptions and expand our understanding of what true medicine can be.
Aspen Psychedelic Symposium 2024 – Hosted by Kevin Franciotti This powerful panel explores the healing potential and complex responsibilities that come with working with Ibogaine, a potent plant-based psychedelic. Moderator Kevin Franciotti guides a heartfelt and informative conversation with Talia Eisenberg, Tom Feegel, and Dr. Lola "Dr. O" Hoba, highlighting personal transformation, medical protocols, and the importance of honoring traditional knowledge. Personal Journeys with Ibogaine Talia Eisenberg shares her recovery from opioid addiction and the founding of BEOND Ibogaine, a medical treatment center in Cancun, Mexico. Her story illustrates the plant's unique power to interrupt addiction and awaken purpose. Tom Feegel, co-founder and CEO of BEOND, shares how his own trauma and long-term sobriety inspired a vision for a safe, respectful, and medically supervised environment for deep healing. Clinical and Cultural Wisdom Dr. Lola Hoba offers insights as a pharmacist and Yoruba herbalist, bridging traditional plant medicine knowledge with modern pharmacology. She describes how iboga works on multiple brain receptors and why it holds so much promise for treating addiction, depression, and trauma. She also cautions about its cardiac risks and calls for respectful, trained facilitation. Safety, Access, and Sustainability Panelists discuss the rigorous safety protocols at BEOND, including ICU-level care, psychiatric screening, and pre-treatment evaluations. They also explore broader questions: How can this medicine be offered responsibly? What does reciprocity mean in practice? BEOND supports Blessings of the Forest, a nonprofit in Gabon that works to stop poaching and protect Indigenous access to the sacred root. A Call for Balance and Respect This conversation highlights the importance of blending science, spirit, and social justice. From trauma healing to sustainable sourcing, each panelist emphasizes the need for compassion, caution, and connection. As laws change and access grows, the panel urges all involved to move forward with care—for the medicine, the people it serves, and the cultures that have stewarded it for generations.
A panel discussion with Jim Harris, Rachel Zoeller, DPT, David W. McMillan, Ph.D., and Manesh Girn, Ph.D. Recorded live at the Aspen Psychedelic Symposium In this riveting and deeply personal conversation, moderator Jim Harris is joined by three pioneers at the intersection of neuroscience, psychedelics, and disability: Dr. Rachel Zoeller (Doctor of Physical Therapy and spinal cord injury survivor), Dr. David McMillan (Assistant Professor of Neurological Surgery at the University of Miami), and Dr. Manesh Girn (neuroscientist and postdoctoral researcher with Robin Carhart-Harris at UCSF). Together, they explore how psychedelics may do far more than treat depression or catalyze mystical experiences—they may also support healing and regeneration in the nervous system. The discussion opens with an acknowledgment that our cultural understanding of psychedelics has mostly focused on their psychological and spiritual effects. But as these experts reveal, the somatic potential of psychedelics is vast and understudied. They delve into promising areas like central and peripheral neuroplasticity, the anti-inflammatory effects of psychedelics, and how these mechanisms might play a role in healing from spinal cord injuries or paralysis. Dr. Girn breaks down the science behind psilocybin's interaction with 5-HT2A serotonin receptors, not only in the brain but also in the spinal cord. These receptors, when activated, may increase neuronal excitability and even help restore lost signaling in damaged motor pathways. He suggests that psychedelics could reopen “critical periods” for neuroplasticity—windows of opportunity for the nervous system to rewire and heal. Rachel Zoeller shares her powerful lived experience as both a physical therapist and a spinal cord injury patient. Her story brings the science to life, particularly her observation that psychedelic experiences help her reconnect to parts of her body affected by paralysis. Psychedelics, she suggests, have allowed her to rebuild mind-body communication and foster compassion toward her own physical limitations. She also underscores the need for patients to cultivate body awareness, meditation, and breathwork as essential tools for safe and effective psychedelic use. Dr. McMillan, who leads outreach at the Miami Project to Cure Paralysis, provides a clinical and safety-oriented perspective. While optimistic about the potential, he urges caution—especially with individuals who have high-level spinal cord injuries and are vulnerable to serious complications like autonomic dysreflexia. He stresses that before we can bring these treatments into clinical settings, we must carefully assess physiological risk, develop precise pharmacological protocols, and prioritize patient safety. The panel also addresses cultural and spiritual interpretations of spasticity. Drawing on both shamanic and somatic perspectives, they propose that these involuntary muscle contractions could be reinterpreted not as dysfunction, but as potential portals for healing, integration, or neurological feedback. The idea that such spasms might help the brain remap muscle groups is discussed as a provocative and hopeful reframe. The conversation wraps with a call to action: to bring together indigenous wisdom, embodied knowledge, rigorous science, and community storytelling in order to chart a new frontier in psychedelic medicine—one that does not leave the disabled community behind. As McMillan puts it, "There's a lesson to psychedelia from paralysis.” It's a reminder that neuropharmacology must consider not just molecules and mechanisms, but people and possibilities. Whether you're a clinician, researcher, patient, or curious explorer, this panel is a moving and illuminating look at how psychedelics could transform not only minds—but bodies. Thanks to Aspen Public Radio, Aspen Psychedelic Resource Center, Healing Advocacy Fund and Aspen Psychedelic Symposium for allowing us to share this podcast. A full agenda from the symposium can be found here.
In this special panel, Joe Moore of Psychedelics Today is joined by Sandor Iron Rope, Lakota spiritual leader and peyote practitioner, and Zach Leary, writer and advocate for psychedelic culture. Together, they explore the critical importance of respecting the cultural, spiritual, and ecological roots of plant medicines. Sandor shares powerful reflections on the Lakota worldview, the trauma of colonization, and the deep spiritual kinship indigenous peoples hold with medicinal plants. Zach reflects on the American counterculture's relationship with psychedelics, highlighting the need to preserve mysticism and community over commercialization. The panel dives into challenges around synthetic versus natural medicines, the risks of spiritual harm when practices are rushed or disconnected from tradition, and the urgent need for indigenous voices at the table as psychedelic policy evolves. Throughout, a theme emerges: slow down, honor kinship, and build right relationship with nature, culture, and spirit. This conversation offers a rare and necessary bridge between indigenous wisdom and the psychedelic resurgence, calling for respect, collaboration, and a return to deep roots to guide future generations. Learn more at ipci.life and psychedelicstoday.com.
This podcast comes from the Aspen Psychedelic Symposium from last summer. It features Diane Goldstein who is the executive director of Law Enforcement Action Partnership, Sarko Gergerian a police officer from Winthrop, Mass and Rick Doblin from MAPS. This panel was introduced by Zach Leary and was a highlight of our trip to Aspen's conference last year. We discuss new ways in which police should or could consider psychedelics and drugs more generally. Thanks to Aspen Public Radio and Aspen Psychedelic Symposium for allowing us to share this podcast.
In this episode Kyle Buller and Joe Moore speak to Zach Leary about his new book "Your Extraordinary Mind: Psychedelics in the 21st Century and How to Use Them". Kyle and Joe join Zach in person for this recording. Zach has lots of hard earned wisdom and gracefully shares it with us and with his readers. We discuss MAPS PS25, Psychedelic Churches, psychedelic overuse and much more. Join us to learn more.
In this episode, Joe Moore welcomes LP Giobbi, an internationally famous DJ, electronic music producer, and jazz pianist. LP shares the story behind Dead House, her project blending Grateful Dead samples with house music. What started as a tribute to her parents during pandemic live streams has become a celebrated musical movement. Joe and LP explore the deeper connection between music and psychedelics. They talk about Bicycle Day, the story of Albert Hofmann's famous LSD bike ride, and how psychedelics can support creativity and personal growth. LP opens up about her own experiences with psychedelics, touring burnout, and how she's learning to reconnect with her body through music and intention. The conversation also highlights LP's work with Fem House, an educational platform that empowers women and gender-expansive individuals in music production. She explains how representation, access, and support are key to shifting the music industry. This is a warm, inspiring, candid episode about breaking barriers, finding your voice, and leading purposefully. If you're in Denver, catch Dead House live at Meow Wolf on Bicycle Day!
In this episode, Kyle Buller speaks with Kayse Geheret, founder of Microdosing for Healing and instructor for Psychedelics Today's Vital program. They explore what it means to be a modern guide in the world of psychedelics. Kayse shares how microdosing has become a key entry point for many and highlights the importance of training, community, and personal growth. They discuss how not all psychedelic work involves facilitation. Some guides support through integration, education, or community organizing. The conversation covers what makes a great guide—qualities like groundedness, empathy, curiosity, and the ability to hold space. They also talk about the growing need for psychedelic-literate professionals in all fields, not just therapy. Kayse and Kyle reflect on the importance of finding the right training—whether for coaching, integration, or peer support. With more people entering the space, education and connection are more important than ever. Whether you're curious about microdosing, thinking of becoming a guide, or simply want to better support your community, this episode offers valuable insight.
Joe Moore sits down with UK-based artist Harry Pack, whose vibrant, surreal, and often psychedelic art has captured the attention of dreamers, psychonauts, and seekers worldwide. Known for channeling the aesthetic of altered states rather than simply replicating them, Harry discusses his journey from childhood doodles to being a full-time artist working digitally in Procreate. He shares stories of deep inspiration from figures like Ott—whose album Hiraeth he recently illustrated—and how art has helped him integrate mystical experiences, recovery, and even potential alien contact. The conversation explores the therapeutic potential of art, the role of storytelling in visionary creativity, and the emergence of recurring themes in Harry's work—most notably, the enigmatic “Purple UFO.” We also get into the importance of community, nature, and play in feeding the creative spirit, and Harry's aspirations to build spaces for collective art-making and integration. Follow Harry on Instagram @harrypackart and @thepurpleufo, and explore his work at harrypackart.com.
In this episode of Psychedelics Today, Joe Moore sits down with South African ethnobotanist and healer Jean-François Sobiecki to explore the rich and largely underrecognized world of African psychoactive plants. With over two decades of fieldwork and research, Jean-François sheds light on the traditional use of these plants in healing, divination, and spiritual practices across Southern Africa. Topics covered include: Jean-François's early inspirations and the ancestral roots of his herbal knowledge His discovery and documentation of 306 African psychoactive plant species The ritual use of Ubuwalu (dream-enhancing emetic infusions) and their role in personal transformation How vomiting, dietary restrictions, and sensory isolation are used as part of initiation processes Cross-cultural parallels between Southern African and Amazonian plant healing traditions The underexplored use of psychoactive plants to treat mental health conditions like schizophrenia and hysteria Ethical fieldwork, indigenous knowledge protection, and the dangers of overharvesting sacred plants Visions for healing and conservation gardens in Africa and the role these plants could play in global mental health Jean-François shares moving stories of his 15-year mentorship with a Northern Sotho diviner and healer, Letti Ponnya, and how she introduced him to African “plant teacher” medicines. His message is clear: Africa has a deep, sophisticated, and scientifically underappreciated tradition of psychoactive plant use that deserves recognition, respect, and further study.
In this inspiring and far-reaching conversation, Joe Moore is joined by Vince Kadlubek, the founder and Chief Visionary Officer of Meow Wolf, the groundbreaking arts and entertainment company known for its massive, immersive art experiences. Together, they dive deep into Meow Wolf's humble DIY origins, its evolution into a multi-city creative juggernaut, and how it intertwines with psychedelic culture and expanded states of consciousness. Vince shares the story of Meow Wolf's formation in Santa Fe, the evolution from a group of passionate friends into a thousand-person company, and the power of belief, creativity, and visionary leadership. He reflects on raising funding from George R. R. Martin and major investors, navigating massive growth, and the challenge of keeping the creative spark alive in the face of institutionalization. They also discuss the upcoming Bicycle Day Portal Takeover at Meow Wolf Denver on April 19, which will feature performances, talks, and immersive experiences throughout the exhibition—with appearances from Reggie Watts, Duncan Trussell, Zach Leary, and more. From the imaginative to the esoteric, Vince and Joe explore the intersection of psychedelics and art, the nature of reality and the imaginal realm, and how to build beauty and wonder into the world around us.
In this episode, Joe interviews Fayzan Rab, an MD candidate (when we recorded) at Emory University with a background in tech at Google and a focus on the intersection of psychedelics, spirituality, and public health. Fayzan shares Emory's unique approach to psychedelic studies, emphasizing spiritual health and the lived religious and existential aspects of psychedelic experiences—what he and his team call “CERT.” The conversation explores Fayzan's collaboration with health economist Elliot Marseille on economic modeling for psilocybin therapy, including their estimate that over 5 million Americans could be medically eligible. He shares insights into the policy challenges around payer systems and the importance of preparing implementation strategies before FDA approval. Fayzan also discusses his groundbreaking research on Muslim perspectives on psychedelics—revealing surprising openness, complex spiritual tensions, and a strong interest in integrating these substances into healing and faith-based frameworks. He highlights the need for inclusive infrastructure and upcoming work with clergy to deepen the conversation. Finally, they explore non-clinical psychedelic use among healthcare workers and entrepreneurs, discussing how psychedelics are being used to address burnout, identity, and life purpose. This is a powerful episode about interdisciplinary collaboration, cultural sensitivity, and the potential for psychedelics to transform not just individuals—but systems. Links Science on Spiritual Health Symposium 2025 Center for Psychedelics and Spirituality - Emory University
In this episode of Psychedelics Today, Kyle Buller is joined by Dr. Hannah McLane, founder of the SoundMind Center and SoundMind Institute. They dive deep into the evolving psychedelic landscape—touching on policy developments in New Jersey, Massachusetts, Pennsylvania, and beyond. Dr. McLane shares her experience testifying in support of psilocybin legislation and discusses the medical frameworks being explored, particularly in contrast to Oregon and Colorado's models. The conversation also explores the essential qualities of effective psychedelic facilitators, emphasizing the importance of self-awareness, lifelong learning, and doing personal inner work. Dr. McLane offers insights into the challenges of entrepreneurship in the psychedelic space, balancing mission-driven work with sustainability, and how neurodiversity and trauma have shaped her approach. Toward the end, the conversation takes a playful and heartfelt turn, reflecting on parenting, the power of curiosity, and the need for more community-centered, human-first spaces for integration and healing. This is a rich, honest, and inspiring dialogue that bridges the personal and political, the clinical and ceremonial, and the visionary future of psychedelics.
In this powerful episode of Psychedelics Today, we sit down with the team behind Natural Medicine Alaska to discuss their groundbreaking efforts to bring psychedelic reform to the state. With some of the highest rates of depression, suicide, and substance use disorders in the nation, Alaska stands at a pivotal moment in the movement for mental health transformation. Joe Moore speaks with Gina, President of Natural Medicine Alaska; David Aloff, an Alaska Native advocate; and Noria Clark, Veterans Coordinator to explore the origins of their movement, the importance of traditional healing protections, and their 2026 ballot initiative to decriminalize plant medicines and establish a regulated therapeutic model. The discussion dives into: The personal journeys that led each guest to this work How Alaska's libertarian spirit aligns with psychedelic reform The push to make Alaska the first state to include Ibogaine clinics in legislation The urgent need for veteran and first responder access to psychedelic therapy Fundraising and grassroots efforts to get the initiative on the ballot The role of Alaska's natural landscape in healing and psychedelic integration With national psychedelic policy at a crossroads, Alaska has the opportunity to become the North Star of this movement. Listen in to learn how you can support this critical campaign! Support Natural Medicine Alaska:
Podcast Show Notes: Psychedelics, Harm Reduction & Ethical Care with Erica Siegal In this episode of Psychedelics Today, Joe Moore sits down with Erica Siegal, founder of Nest Harm Reduction and Shine Collective, for a deep conversation on psychedelic harm reduction, ethical facilitation, and the evolving psychedelic landscape. Erica shares her journey from the Grateful Dead lot scene to festival harm reduction, social work, and leading initiatives to support survivors of psychedelic-related harm. The conversation covers: Erica's background in hospitality, social work, and psychedelic harm reduction The mission of Nest Harm Reduction in offering psychedelic therapy, integration, and community education The work of Shine Collective, a nonprofit supporting survivors of psychedelic harm and abuse The challenges of ethical facilitation, power dynamics, and the importance of clear boundaries How the psychedelic community can better address harm, accountability, and survivor support The intersection of Jewish spiritual traditions and psychedelics through Shefa This episode is a must-listen for those passionate about harm reduction, ethical psychedelic practice, and building a safer, more accountable psychedelic culture.
Army Ranger to consultant to leading one of the most respected psychedelic retreat organizations, detailing how meditation and psychedelic therapy helped him heal from trauma. The conversation covers: Neal's military background and his path to psychedelics The mission and structure of Beckley Retreats, an offshoot of the Beckley Foundation How their retreats integrate meditation, preparation, and integration for long-lasting benefits The legal landscape of psilocybin in Jamaica and the Netherlands Challenges and lessons from running a psychedelic retreat business The future of psychedelics, from global access to potential federal policy shifts Whether you're curious about immersive psychedelic retreats, the intersection of mental health and psychedelics, or the evolving legal landscape, this episode is packed with insight. Learn more about Beckley Retreats here. Hear more from Neil on Psychedelics Today here.
In this episode, Joe Moore of Psychedelics Today sits down with Paul Austin, founder of The Third Wave, to dive deep into the evolution of microdosing and its growing role in psychedelic culture. Paul shares how his journey with microdosing LSD led him to launch The Third Wave in 2015 to make psychedelics more accessible through education. The conversation explores the latest research on microdosing, including clinical trials demonstrating its potential benefits for depression, mental clarity, and creativity. Paul and Joe discuss the nuances of different microdosing protocols, the role of psychedelics in performance optimization, and the impact of these substances on neuroplasticity. They also tackle key challenges, such as the lack of robust clinical research due to regulatory hurdles and the perceived risks associated with overuse. Beyond microdosing, they touch on the broader psychedelic landscape—regulatory shifts, emerging coaching models, and the future of psychedelic-assisted transformation. The discussion even ventures into intriguing intersections between psychedelics, AI, and the possibility of extraterrestrial intelligence. Tune in for a thought-provoking conversation on where microdosing fits into the larger psychedelic resurgence.
In this episode of Psychedelics Today, Joe Moore sits down with Louis Dorian, the visionary behind Psychedelist, a groundbreaking global platform designed to support the emerging psychedelic movement. Described as a “cyber city” for all things psychedelic, Psychedelist connects individuals with treatment providers, educators, facilitators, legal experts, and even vetted product vendors in an effort to enhance accessibility and safety in this evolving space. Louis shares his journey into psychedelics, from early rave days to a transformative encounter with high-dose LSD and psilocybin that shaped his worldview. He opens up about the struggles of navigating trauma, loss, and the shortcomings of Western psychiatric care, leading him to develop his own trauma-processing techniques blending meditation, breathwork, and psychedelics. The conversation also dives deep into the broader implications of drug prohibition, harm reduction, and the role of skill-building in responsible psychedelic use. Whether you're a seeker, a skeptic, or a professional in the field, this episode offers a compelling exploration of the psychedelic landscape and the power of intentional community building. Resources: Visit Psychedelist Follow Louis Dorian on Instagram: @psychedelist More from Psychedelics Today: Website Tune in for an eye-opening discussion on the future of psychedelics, regulation, and self-exploration!
In this episode of Psychedelics Today, Joe Moore is joined by Neeka Levy and Zach Skiles of Heal Ukraine Trauma, a nonprofit bringing psychedelic-assisted therapy to veterans and civilians affected by war. They discuss the organization's origins, the impact of intergenerational trauma in Ukraine, and the evolving role of psychedelic treatments in a war-torn nation. Nika, a first-generation Ukrainian-American and neuroscience-trained psychiatric nurse practitioner, and Zach, a Marine veteran turned psychologist, share their journey into this work, highlighting the importance of group ketamine therapy as a scalable, culturally aligned solution. They explore Ukraine's complex regulatory landscape, the need for rigorous research, and the challenges of working in a war zone. They also touch on the role of psychedelics in processing moral injury, the importance of including family members in healing, and how Ukraine's collectivist culture influences therapeutic approaches. With insights on historical trauma, ethical considerations, and the potential future of MDMA and psilocybin therapy in Ukraine, this conversation sheds light on a vital, evolving effort.
In this episode, Joe interviews Josh Lipson, a Ph.D. candidate in clinical psychology at Columbia University, whose research explores the relationship between psychedelics, mystical experiences, and mental health. He discusses the complexities of studying psychedelics in real-world settings, the role of metaphysical perspectives in research, and why different individuals respond to psychedelics in such varied ways. Lipson shares his personal journey into psychedelic research, the challenges of interdepartmental collaboration, and the evolving landscape of modern psychedelic science. He also talks about: The importance of integration after psychedelic experience Why mystical experiences may not be the only path to healin The balance between stability and the chaos psychedelics can introduc The need for diverse perspectives and ways of knowing in psychedelic researc How psychedelics have shaped global consciousness and cultural perspectives and more! For links, head to the show notes page.
In this episode, Joe interviews Nico and Susan Simon: Co-founders of JourneyŌM, a concierge service looking to address the question many people are asking: How do you find the right facilitator? Through a dedicated vetting process, JourneyŌM is adding a layer of risk reduction and accountability to this strange new world, by traveling the country and amassing a network of trusted facilitators who work with all types of medicines and modalities. By getting to know guides and seekers personally, they're able to offer possible matches – and they usually agree on who would work best with each other. They talk about: Their process for building their network and finding the right facilitator for someone Their concept of going “beyond the bio” and getting to the heart of what drove someone toward becoming a guide Susan's struggle with supporting Nico through his psychedelic healing, and the need for support options for spouses not sharing in the experience The importance of community and the amazing work Nico has seen in men's groups The healing powers of movement and living as your authentic self and more! If you're interested in JourneyŌM's matchmaking, head to their site and take their assessment to begin the process. For links, head to the show notes page.
In this episode, Joe interviews renowned chemist, filmmaker, and journalist, Hamilton Morris. After originally backing down from its first attempt in 2022, the DEA is once again looking to apply schedule I status to two lesser-known compounds: DOI (2,5-dimethoxy-4-iodoamphetamine) and DOC (2,5-dimethoxy-4-chloroamphetamine). For decades, DOI and DOC have been incredible tools for researchers studying serotonin receptors, showing promise for chronic pain, anxiety, depression, and more. Originally recorded as a livestream in November, we felt this discussion deserved more attention, as Morris was present during the hearing and saw first-hand the damage that can come from the combination of immense overreach and outdated beliefs. He talks about: The bureaucratic mess behind so much of what the DEA doe The safety profile and research capacity of DOI and DOC and complete lack of data showing recreational us The DEA's claim that advocates weren't expert The fight to protect the Sonoran Desert toad and more! While we wait for the conclusion of the hearing, head to Hamilton's Patreon to hear his daily breakdowns. For links, head to the show notes page.
In this episode, Joe interviews Jeremy Falk: certified instructor and training program developer for Kama Flight; and Dr. David Rabin, MD, Ph.D.: board-certified psychiatrist and neuroscientist, co-founder & chief Medical Officer at Apollo Neuroscience, and advisor to Kama Flight. Kama Flight is a wellness modality for partners, inspired by the movements of Watsu therapy, Thai massage, 5Rhythms, tango, improv dance, and Acroyoga. At the heart of it is the dynamic between the two people engaged in the dance (the ‘base' and the ‘voyager'), which touches on collaboration, leadership, receptivity, strength, surrender, and most importantly, trust. The communication and instant feedback shared between the partners mixed with the healing energy of the somatic movements results in moving stuck energy out of their bodies while also making them more comfortable with touch, agency, and consent – which could be extremely beneficial toward preparing for a psychedelic experience. They talk about: The four principles behind Kama Flight: permission, presence, polarity, and play The humility and humor in people trying (and failing) some of the movements, and how that is healing in itself The huge benefit in people switching between the roles of base and voyager What kind of growth they've seen in clients over extended periods of time The importance of making time for pleasure in our lives and more! For links, head to the show notes page.
In this episode, Joe interviews Ariel Clark: Anishinaabe attorney and co-founder of the Psychedelic Bar Association, a national association of lawyers involved in the highly-regulated ecosystem of psychedelic law. She talks about ethics: How do the different societal norms of each lineage we carry interact with each other? What is the cultural framing that informs those ways of knowing, and do we align with it? Is there a code of ethics we can all agree on? As the rush to legalize psychedelics increases, Clark finds herself at a crossroads of wondering if our actions are really of service to the greater good: Can the overculture legalize psychedelics effectively, while doing less harm to Indigenous culture and the medicines themselves? She discusses: The challenges of working in psychedelic law with all of the other factors at play: How do you ethically support a client? The idea that these medicines can have agency – even the synthetic ones Shifting from a Western mind state of “what are my rights?” to an Indigenous frame of: “What are my responsibilities?” Her story of healing from debilitating back pain with psychedelics and spiritual alignment The need for public education to be at the center of future legislation attempts and more! For links, head to the show notes page.
In this episode, Joe interviews Angie Roullier: longtime veteran of the cannabis industry and author of the book, Pot for the People: The Plant, the People, and the Shop Policies of Cannabis. Diagnosed with the neurological disorder, Charcot-Marie-Tooth (CMT), Roullier tells the story of how cannabis replaced all her medications, which led to a personal journey and career centered on cannabis education. She talks about the challenges patients face in today's rapidly evolving cannabis markets, misconceptions surrounding cannabis, the ignorance of many budtenders, and how not knowing enough can lead to an underwhelming high. She discusses how she educated people in shops and how her book was written to teach people how to ask the right questions to not only ensure a safe and effective experience, but to also give them the experience they're looking for. She talks about: -The early days of Michigan's medical program and the state's current attempt to essentially combine medical and recreational markets -Cannabis culture and an emerging “I can take more milligrams than you” bravado -Why understanding terpenes and the entourage effect can be game-changing toward finding a preferred strain -The rise of hemp-derived THC products, the regulatory loopholes they exploit, and their potential risks -Why home growers and caregivers are essential to the cannabis ecosystem and more! For links, head to the show notes page.
In this episode, Kyle interviews Tommy Aceto: former Navy Seal and trauma medic, and now, ambassador for the Veteran Mental Health Leadership Coalition and advisor at Beond Ibogaine. He talks about how much the psychedelic space focuses on healing and mental health, but doesn't talk enough about the overall wellness that can come from a consistent practice: that the more you become aware of your body, emotions, and breath, the more robust your neural pathways will become – and that you can actually change your neurochemistry and build a more energetically powerful system. With these pathways being opened, fewer psychedelic experiences are necessary, and with practice, these mind states can be achieved simply through meditation or breathwork. The idea of surrender and entering a state of receivership is scary, but he believes the most important skill to begin that transformation is to learn how to truly let go. He also talks about: What the psychedelic scene is like in Nashville and the south His work with the Kentucky Opioid Abatement Advisory Commission and what happened with the bill to grant 42 million for ibogaine research His most powerful 5-MeO-DMT experience and how it reconnected him with the divine The science and practice of gratitude: how reframing painful experiences can actually rewire the brain How cold exposure (notably ice baths) can prepare your system for a psychedelic experience and more! Happy New Year from all of us at Psychedelics Today. Let's hope for big psychedelic wins in 2025! For links, head to the show notes page.
In this episode, Joe interviews Melanie Curtis: world record professional skydiver, keynote speaker, coach, co-host of the Trust the Journey podcast, and author of How to Fly: Life Lessons From a Professional Skydiver. Curtis shares her journey from taking her first transformative leap out of an airplane to becoming a leader in skydiving, public speaking, and now, the integration of psychedelics into personal growth. She discusses the parallels between skydiving and working with psychedelics – most notably in the idea of leaping into the unknown, trusting the universe, and in the potential that can be unlocked after you've come back down to earth. While relatively new to the psychedelic space, she stresses the importance of sharing your story and opening up dialogues, no matter how small you think your voice may be. She talks about: Her early psilocybin journeys and recent ayahuasca experiences How she came out of the psychedelic closet to her Mother, and learning of the power of small steps and trusting the universe Realizing how her Father's behavior affected her, and how it has made her more connected to her femininity and other women The power of confidence and how much better we'd all be if the fear of humiliation wasn't so prominent in our lives and more! For links, head to the show notes page.
In this episode, Joe interviews Dan Ronken: licensed professional counselor and addiction counselor with a private practice in Boulder, CO, called Inclusion Recovery, and lead trainer and facilitator for the Integrative Psychiatry Institute (IPI). He tells his story of going from a sponsored BMX racer to three stints in rehab before the age of 14, and what he's learned from his experiences in recovery over the years: that there is a wide range of what ‘in recovery' actually means, that abstinence-only and 12-step models don't work for many, that connection and community – and consistency in both – are enormous parts of what actually leads to overcoming an addiction, and more. As recovery communities cautiously begin to talk about psychedelics, he highlights the importance of nuance in understanding addiction, the need for open-mindedness toward new therapeutic approaches, and the need for diverse support networks that welcome discussions around psychedelics. He talks about: Inducing alcohol cravings before an intramuscular ketamine shot as a way of using neuroplasticity to rewire the brain's relationship with alcohol How Bill Wilson, co-founder of Alcoholics Anonymous, benefitted greatly from LSD in the 50s, and how Ronken originally scoffed at such a concept The growing visibility of psychedelics in popular media, as seen in shows like “Loudermilk” and “Ted Lasso” The benefits of sober communities coming together for active and healthy activities and more! For links, head to the show notes page.
In this episode, Joe interviews Shauheen Etminan, Ph.D.: co-founder of VCENNA, a drug discovery and development company, and Magi Ancestral Supplements, which sells nootropics inspired by ancient Eastern traditions. He discusses his journey into the world of plant extraction, how he first discovered compounds like Haoma and Harmaline, and why he decided to bring Iranian tradition to the psychedelic renaissance. He explores the similarities between psychedelics and experiences found in mystical traditions, and how that historical context can inform modern psychedelic practice. He sees this exemplified most with dream recollection, attending to the emotions found within dreams, and the concept of wakeful dreaming, where one can access unconscious insights consciously, through the liminal (or hypnagogic) state between dreaming and wakefulness. He discusses: Zoroastrianism and how the teachings of Zarathustra on understanding morality have inspired hi Syrian Rue in Iranian culture, and how it compares to the Banisteriopsis Caapi vine: Is it actually stronger than ayahuasca Henry Corbin's practice of embodied imagination and Jung's concept of active imaginatio Other less-discussed compounds he's interested in, like Ephedra and Saffron and more! For links, head to the show notes page.
In this episode, Joe interviews Paul Grof: research psychiatrist, clinician, author, brother of Stanislav, professor of psychiatry at the University of Toronto, and director of the Ottawa Mood Disorders Center. He talks about his extensive career in psychiatry, and how trying to understand the cause of mood disorders led him to focusing on the very nature of consciousness. He believes that consciousness is a collaborative creation between the brain, body, and external fields, and that the key to connecting with the mechanistic side of academia is through talking about the unexplainable – near death experiences, pre-cognition, remote viewing – and of course, them having positive non-ordinary experiences through psychedelics or other means. He talks about how much we're connected, how much our bodies remember, and how much society could change for the better if enough people experience the transpersonal. He also discusses: His thoughts on legal frameworks, education, integration, and whether or not psychedelics will get stuck in psychiatry The importance of new study designs in research, as double blinding doesn't make sense for psychedelics Concerns over spiritual emergence and emergencies: How much is the responsibility of the therapist or facilitator? The global rise in depression and addiction, especially in the younger generation, and the need for techniques for people to help themselves The work he's doing with remote healing circles, using strong intention, positive emotions, and visualized healing and more! For links, head to the show notes page.
In this episode, Joe interviews Kat Murti: executive director of Students for Sensible Drug Policy (SSDP), the largest nationwide network of students fighting to replace the War on Drugs with policies rooted in evidence, compassion, and human rights. She talks about how she became interested in drug policy, which not surprisingly aligns with the many problems of The War on Drugs: how it's a war on people, personal liberty, and our communities; how laws are not effective in enforcing morality; and how getting in trouble with the law often incentivizes more illegal activity. We all know that our current system doesn't work and that the drug war no longer appeals to most reasonable people, but how can we move towards sensible policy? She discusses previous successes (both at SSDP and before), and some of their current projects, from the work they're doing with fentanyl strip training and distribution, to education work at festivals and their program, “Just Say Know.” She talks about: How drug policy isn't going to look the same everywhere and shouldn't: How do we effectively use different models in different places together for the benefit of everyone? The dangers of forcing drug users through drug courts and treatment centers The repealing of Oregon's Measure 110 and how it's unfair to blame its failure on problems that already existed in the state Their new focus on how the War on Drugs specifically affects women and reproductive rights, inspired by Louisiana recently scheduling Mifepristone and Misoprostol and much more. The SSDP's biggest battle now is fighting the DEA's attempted scheduling of DOI and DOC, two compounds that have been used in research for decades and pose no real threat to safety – which would drastically derail a ton of research. They just completed a 10-day hearing with the DEA. Watch Joe and Hamilton Morris' breakdown here, and stay tuned to SSDP and PT for updates. For links, head to the show notes page.
In this episode, Joe interviews Howard Kornfeld, MD: renowned pain medicine expert, addiction specialist, early pioneer in psychedelic medicine, and currently the director of recovery medicine at Recovery Without Walls. As a leader in the utilization of buprenorphine, he talks about how it came about as a treatment for addiction and chronic pain, its similarities to MDMA, and how its fast-tracked FDA approval could give us clues on how to get MDMA approved. He also dives into the history of ketamine, its unique effects compared to other substances, its potential for abuse, and what can happen with overuse. And he talks a lot about the connection he sees between psychedelics and the prevention of nuclear war, inspired by Sasha Shulgin's opinion that nothing changes minds faster than psychedelics. He points out that when there is darkness, there is light: Albert Hofmann's famed bicycle trip on acid happened 3 months after the nuclear chain reaction was invented. Can the growing use of psychedelics inspire the kind of change we need to save the world? He also discusses: The need for new study designs as we come to terms with the fact that double-blind studies don't really work with psychedelics Criticisms of the FDA's denial of MDMA: Was the process unfair? His predictions that advocates will begin pushing to decriminalize MDMA at the state level The books, Tripping on Utopia and Drugged How he played a part in prisons ending the practice of killing prisoners with cyanide gas and more! For links, head to the show notes page.
In this episode, Joe interviews Veronica Lightning Horse Perez: therapist, speaker, author, activist, and co-chief proponent for the Natural Medicine Health Act of 2022 (Prop 122); and Sean McAllister: attorney specializing in the regulatory, health care, business, and religious freedom aspects of psychedelic medicines, and one of the drafters of Prop 122. This episode was recorded live at the Plant Medicine Cafe in Denver, CO – which served as an unofficial Prop 122 headquarters – and cohosted by Meaghan Len, co-founder of the U.S.' first ayahuasca church, Sanctuary of the Sovereign Heart. They dive into the details of Prop 122 and discuss why it's the most freeing legislation we've seen, but also very complicated in the clash between an expensive regulated side and a risky and ambiguous decrim side. While the implementation process continues, they've learned that there is still a huge need for public education, and that one of the most important tasks now is to be hyper aware of how legislators will try to change what people already agreed on. They discuss: The Federal vs. state legality issues we still see even after such sweeping legislation The huge gap in understanding why Indigenous communities are upset and why they need to be included in all discussions The Religious Freedom Restoration Act and the complications of religion when many of us simply feel spiritual The natural vs. synthetic fallacy and the future of churches offering a synthetic sacrament The ontological shock many have after a big experience and why churches and community are needed to help guide people and more! For links, head to the show notes page.
In this episode, Joe interviews two members of the Heroic Hearts Project: Founder and President, Jesse Gould; and Director of Development and Head of Family Relations, Allison Wilson. Gould gives a background of Heroic Hearts Project and discusses their current projects and future goals, and Wilson talks about her nonprofit, The Hope Project, and its recent merger with HHP to bring more of a focus to the other side of veteran healing: the families of veterans. While Heroic Hearts and other veteran-aligned organizations have been an answer to many vets unable to find help otherwise (and frustrated with the inconsistencies of the VA), they talk a lot about that missing piece – how crucial it is to have family involved in a veteran's reintegration, and how that healing can impact future generations. "The Veteran's Guide to Psychedelics: A Preparation and Integration Workbook" was recently released, with all proceeds going to HHP, and they are hosting their first Gala event, "Operation: Freedom To Heal," this week, December 5, in Los Angeles. The goal of the event is to fundraise, gather community, and recognize the supporters who have gotten Heroic Hearts to where it is today, and will feature live and silent auctions and a performance by Melissa Etheridge. Email Allison@heroicheartsproject.org if you'd like to attend. For links, head to the show notes page.
In this episode, Victoria interviews Max Montrose: Founder of the Trichome Institute, a company offering online courses and certifications on cannabis. Montrose explores the scientific and sensory aspects of cannabis, diving into the role of the aromatic compound, indole, and how the fresher and more aromatic (usually pungent) the flower is, the higher chance for having a more psychedelic experience. He dives into ways to maximize the psychedelic nature of cannabis, largely through “interprening,” which is his method for learning about a plant's effects from smelling buds, measuring your sense of sensation and where you feel the smell is hitting you. And he talks a lot about intention and how the power of a cannabis experience can be determined by the reverence you have for the plant and the intention you put behind each inhale: It is a “total reflection of how much you care.” He also discusses: The range of cannabis effects: how it can be just weed – something mindlessly smoked all day with a slight numbing effect – or an incredibly powerful, life-changing experience The importance of skillset being added to the concept of set and setting: the skills you have (and can practice) for helping you create your own setting to get through a tough time Issues with the legal cannabis industry about accuracy of strains, shelf life, and the ability to smell the product The lack of money in cannabis research: Why is no one funding research into indole chemistry? Why indica and sativa are not accurate terms, and how aroma is more of a factor than we realize and more! For links, head to the show notes page.
In this episode, Kyle interviews Pierre Bouchard, LPC, LM: therapist, minister, and former professional vinyl DJ specializing in psychedelic-assisted psychotherapy and ministry. Bouchard introduces his 3-axis framework for psychedelic integration, which looks at the personal, the transpersonal, and, with time, seeing how the lessons learned from non-ordinary experiences and personal work are expressing to the world: How can we use what we've learned to show up better? How can we use our gifts to be of service to others? What is stopping us? He also talks about the importance of building a foundation for holding the experience of a psychedelic journey - that you have to first build an ego to later dissolve it - but recognizes the tricky balance of not strengthening an ego so much that it gets in the way. He discusses: The broad scope of what someone can mean when they say "psychedelic healing" The importance of keeping the 3 axes in harmony - that you should always be attending to each Why someone beginning a healing journey needs to be smart, curious, and desperate The challenge of discerning between an entity or a projection: How do we know what to take from that experience? Why practitioners and therapists need to find a balance between being confident and humble and more! For links, head to the show notes page.
In this episode, Joe interviews Bria Tavakoli, LPCC, MA, MS: a therapist specializing in relational and sex therapy, with a focus on helping clients integrate psychedelic experiences. She shares her personal journey with psychedelics and how they unlocked deep trauma, allowing her to develop a level of comfort with intimacy, love, and her sexuality. She talks about the parallels between psychedelic journeys and sexual experiences, and how both can be gateways to unexplored parts of ourselves, as well as catalysts for healing and transformation. She discusses society's cultural shame surrounding our sexuality, why we need to view sexuality from a wellness-based model, and how psychedelics can help couples grow together, and at times, really challenge their relational structures. When asked how to combine sex and psychedelics, she answers, “very carefully.” She also discusses: The immense importance of creating a safe space for couples discussing their intimacy How clients reporting sexual concerns is usually a cheat code to determining what their real issues are Ethical and practical considerations for combining psychedelics and sex therapy, related to stories of concerning sexual behavior in the space Why humor and lightness is so important in this work The importance of honoring individual capacity and being true to yourself when exploring new experiences and more! For links, head to the show notes page.
In this episode, Kyle interviews Juan Pablo Cappello: co-founder and former CEO of Nue Life Health, whose assets were subsequently acquired by Beckley Waves. Cappello discusses the current challenges and controversies facing a ketamine industry that has moved much faster than anyone anticipated, and stresses the need to create industry-wide standards – especially for at-home ketamine – before the government imposes its own standards on us. Citing the Matthew Perry case and other bad behavior from providers, he talks about the risks of overpromising and underdelivering, the lack of integration in the majority of at-home ketamine frameworks, and how profit-driven, subscription model motives have overshadowed patient care and ethical practices. He also discusses: The complications from personal perspectives and passions shifting after a psychedelic experience, and how that can change over time The FDA's recent rejection of MDMA: What would have happened to MDMA if it had been approved? Hope for more Native American churches, and what they can learn from the DEA's denial of Soul Quest The story of a bump of cocaine ruining the hope for cannabis to be decriminalized under the Carter administration Our current Wild West of gas station CBD, Delta-8, and barely-regulated vapes and more! For links, head to the show notes page.
In this episode, Kyle interviews Geoff Bathje, Ph.D.: licensed psychologist, researcher, former Full Professor, and co-founder of Sana Healing Collective, a Chicago-based non-profit focusing on ketamine-assisted therapy and psychedelic integration. He talks about what he feels is one of the largest factors in our mental health crisis: the individualistic and neoliberal lens Western culture has placed on mental health and how it neglects the massive systemic and relational factors that are affecting us all. He digs into how we got so alienated and how psychedelics and non-ordinary states of consciousness can not only help us think critically and solve problems, but also move us out of this individualistic framework of healing and more into a collective one. How do we use psychedelics to fix our relationships and find our community? He discusses: The challenge of knowing when to work for relationships and when to just end them, especially in the afterglow of a big experience Group ketamine experience vs. individual, how groups can help facilitators find patterns, and how ketamine works with somatic therapy His paper, “Psychedelic integration: An analysis of the concept and its practice” and his visual model of integration showing the different domains of our personal experience What he thinks will happen next in drug development: Will therapy be left out after Lykos' failure with MDMA? The importance of moving beyond aggressive criticism and moving into world building and more! For links, head to the show notes page.
In this episode, Joe interviews Thomas Feegel: co-founder of Beond Ibogaine, an ibogaine treatment and research facility in Cancún, Mexico. When Feegel first heard of ibogaine 16 years ago, he found that people were having great success, but nobody could recommend where to go for treatment. So he worked to create what was needed: a combination of a hospital, mental health treatment facility, retreat center, and resort, with the proper infrastructure in place, employees with ICU experience, exhaustive HIPAA-compliant admission criteria, regular data collection, and a major focus on safety. Addressing the recent Rolling Stone article about the tragic death of a patient at Beond in 2022 (interestingly, 2 days after his initial dose), he discusses what he feels was inaccurate, largely related to what could be perceived as a suggestion that there wasn't enough screening or that corners were cut. With no official reason given for the patient's death, it brings into question just how safe one can be, especially with people whose bodies and hearts have been through so much. How much hidden harm is created by the stress of PTSD and addiction? He discusses: The complexity of journalism and drawing conclusions from limited information The limitations of conventional addiction treatments and the sad numbers around how many people stick with rehab The importance of collecting as much data as possible about each patient, at regular intervals, prior to, during, and after the experience The need for a regulating group to create standards around admission and administration procedures for ibogaine and more! We're releasing this episode on Veterans Day because Beond's program was co-developed by veterans, military medical personnel, and active-duty law enforcement officers who have seen how much ibogaine can help. If you know a vet who is struggling, be sure to let them know what's possible with psychedelic therapy. For links, head to the show notes page.